Cancer and Aging Research Group Chemotherapy Toxicity Tool (CARG-TT)

The Cancer and Aging Research Group Chemotherapy Toxicity Tool estimates the risk of severe chemotherapy toxicity in older adults.

Age, years
< 720≥ 72+2
Cancer type
Other0GI or GU+2
Dosage (for first dose of chemotherapy)
Reduced dose0Standard dose+2
Number of chemotherapy drugs
10> 1+2
Creatinine clearance, ml/min
≥ 34 mL/min0< 34 mL/min+3
Hearing
Excellent/good0Fair/poor/totally deaf+2
Number of falls (in the past 6 months)
None03 pts≥ 1
Needs help taking meds
No0Yes+1
Walking ability (within one block)
Not limited0Limited+2
Social activity
Not deceased due to health0Deceased due to health+1

Indications for Use

Used in adults ≥65 starting a new chemotherapy regimen to estimate risk of grade ≥3 toxicity and guide dose intensity or regimen selection. Supports shared decision-making and aligns therapy with functional status, comorbidity, and geriatric vulnerabilities (ASCO geriatric guideline recommends its use 1 [Level I evidence]). Externally validated across multiple cohorts with predictable risk gradients (eg, 36.7% vs 70.2% toxicity in low vs high risk groups 2 [Level II evidence]).

Insights & Cautions

Identifies older adults at low/medium/high risk for grade 3–5 chemotherapy toxicity, with external validation showing risk increases from ~37% to ~70% across strata 1 [Level II evidence]. Most useful when paired with a full geriatric assessment, as recommended by ASCO 2 [Level I evidence]. Cautions: not regimen‑specific, less accurate for targeted agents, modest discrimination (AUC ~0.65–0.74), and should guide but not dictate dose reduction or regimen choice.